Voxelotor Treatment Interferes With Quantitative and Qualitative Hemoglobin Variant Analysis in Multiple Sickle Cell Disease Genotypes.

Rutherford-Parker, Nicola J; Campbell, Sean T; Colby, Jennifer M; Shajani-Yi, Zahra

Rutherford-Parker, Nicola J; Campbell, Sean T; Colby, Jennifer M; Shajani-Yi, Zahra.

Afiliação

Rutherford-Parker NJ; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.
Campbell ST; Department of Pathology, Montefiore Medical Center, Moses Division, The Bronx, NY.
Colby JM; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.
Shajani-Yi Z; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN.

Am J Clin Pathol ; 154(5): 627-634, 2020 10 13.

Article em En | MEDLINE | ID: mdl-32561909

Assuntos

Anemia Falciforme/tratamento farmacológico; Benzaldeídos/uso terapêutico; Genótipo; Fármacos Hematológicos/uso terapêutico; Hemoglobinas/análise; Pirazinas/uso terapêutico; Pirazóis/uso terapêutico; Anemia Falciforme/sangue; Anemia Falciforme/genética; Hemoglobina Falciforme/análise; Hemoglobinas Anormais/análise; Humanos

Palavras-chave

GBT440; HbS percentage; Hemoglobin S; Interference; Oxbryta; Sickle cell disease; Voxelotor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazinas / Pirazóis / Benzaldeídos / Hemoglobinas / Genótipo / Fármacos Hematológicos / Anemia Falciforme Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google